General Announcement::IX BIOPHARMA TO PRESENT WAFERMINE PHASE 2 STUDY RESULTS
Issuer & Securities
Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No
Announcement Details
Announcement Title
General Announcement
Date &Time of Broadcast
05-Nov-2018 17:21:39
Status
New
Announcement Sub Title
IX BIOPHARMA TO PRESENT WAFERMINE PHASE 2 STUDY RESULTS
Announcement Reference
SG181105OTHRAPND
Submitted By (Co./ Ind. Name)
Lee Wei Hsiung
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Please refer to the attachment.
Attachments
Press Release_iX Biopharma to Present Wafermine Results at BIO-Europe 6 Nov 2018.pdf
Total size =301K
Related Announcements
Related Announcements
07/11/2018 07:00:10